Relay Therapeutics
RLAY
RLAY
161 hedge funds and large institutions have $1.64B invested in Relay Therapeutics in 2023 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 63 increasing their positions, 39 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.9% less ownership
Funds ownership: 107.95% → 107.05% (-0.9%)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
24% less capital invested
Capital invested by funds: $2.16B → $1.64B (-$518M)
Holders
161
Holding in Top 10
4
Calls
$1.42M
Puts
$1.02M
Top Buyers
| 1 | +$19.8M | |
| 2 | +$18.6M | |
| 3 | +$16.7M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$11M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$9.4M |
Top Sellers
| 1 | -$73.5M | |
| 2 | -$12.4M | |
| 3 | -$10.8M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$9.58M |
| 5 |
HMC
Harvard Management Company
Boston,
Massachusetts
|
-$8.91M |